Sionna Therapeutics, Inc. (SION)
7.85
+0.23
(+3.02%)
USD |
NASDAQ |
Sep 11, 16:00
7.84
-0.01
(-0.13%)
After-Hours: 20:00
Sionna Therapeutics Market Cap : 354.54M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 354.54M |
| September 10, 2026 | 344.15M |
| September 09, 2026 | 337.83M |
| September 08, 2026 | 329.70M |
| September 04, 2026 | 324.28M |
| September 03, 2026 | 304.86M |
| September 02, 2026 | 330.15M |
| September 01, 2026 | 291.76M |
| August 31, 2026 | 272.34M |
| August 28, 2026 | 265.11M |
| August 27, 2026 | 273.70M |
| August 26, 2026 | 278.66M |
| August 25, 2026 | 282.28M |
| August 24, 2026 | 252.47M |
| August 21, 2026 | 238.92M |
| August 20, 2026 | 249.31M |
| August 19, 2026 | 282.28M |
| August 18, 2026 | 268.28M |
| August 17, 2026 | 266.92M |
| August 14, 2026 | 291.76M |
| August 13, 2026 | 295.37M |
| August 12, 2026 | 282.28M |
| August 11, 2026 | 230.34M |
| August 10, 2026 | 203.24M |
| August 07, 2026 | 2.305B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.241B |
| August 05, 2026 | 2.138B |
| August 04, 2026 | 2.256B |
| August 03, 2026 | 2.220B |
| July 31, 2026 | 2.124B |
| July 30, 2026 | 2.109B |
| July 29, 2026 | 2.020B |
| July 28, 2026 | 2.098B |
| July 27, 2026 | 2.046B |
| July 24, 2026 | 2.060B |
| July 23, 2026 | 1.986B |
| July 22, 2026 | 2.030B |
| July 21, 2026 | 2.128B |
| July 20, 2026 | 2.060B |
| July 17, 2026 | 2.227B |
| July 16, 2026 | 2.041B |
| July 15, 2026 | 2.000B |
| July 14, 2026 | 1.920B |
| July 13, 2026 | 1.981B |
| July 10, 2026 | 2.041B |
| July 09, 2026 | 2.026B |
| July 08, 2026 | 1.983B |
| July 07, 2026 | 2.025B |
| July 06, 2026 | 1.944B |
| July 02, 2026 | 1.983B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 130.59B |
| ACADIA Pharmaceuticals, Inc. | 4.790B |
| Immunic, Inc. | 155.82M |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
| Anika Therapeutics, Inc. | 279.17M |
Market Cap Related Metrics
| PEG Ratio | -0.1382 |
| Price to Book Value | 1.334 |
| Price | 7.85 |
| Earnings Yield | -27.63% |
| PEGY Ratio | -0.1382 |